← Leaderboards
Thomas James Walsh
Seattle Inst For Biomedical/Clinical Res
$192,278
Attributed
$384,556
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $199.6K · FY2012–13$200K$150K$100K$50K$0
'12
'13
Funding mix
By agency
NIH$384,556 · 1
By mechanism
R01$384,556 · 1
Top collaborators
- Molly Mcdonough Shores3 shared
Most similar at Seattle Inst For Biomedical/Clinical Res
Same institution · by research overlap
- Shehzad Basaria$7,488,405
- Egidio Del Fabbro$1,132,539
- Molly McDonough Shores$731,422
Others in their field
Top investigators on “Adverse Event”
- James Dennis Neaton · Northwestern University$97,240,825
- Rose A Gubitosi-Klug · Case Western Reserve University$69,866,183
- Lisa P Jacobson · Johns Hopkins University$56,753,115
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$54,912,059
- Robert J Gray · Dana-Farber Cancer Institute$49,428,707
- Susan Abushakra · Alzheon, Inc.$47,690,244
Research focus
Adverse EventAfrican AmericanAgingAmericanBenefits And RisksBiopsyBlood ClotBlood CoagulationCardiovascular SystemCessation Of LifeClinically RelevantClinically SignificantClinical TrialsCohortDatabasesData QualityDeep Vein ThrombosisDesignDiabetes MellitusDistant MetastasisDrug FormulationsEpidemiologic StudiesEpidemiologyAdverse Effects